XBI (SDPR S&P Biotech ETF) Posied for Upside Continuation?

Mike Paulenoff By

XBI (SDPR S&P Biotech ETF) continues to carve out a high level bullish digestion pattern that when complete, should resolve itself in an upside continuation thrust that propels XBI to a next target zone of 85.80-86.20. Only a decline that prints 82.60 will invalidate the current, promising near term set up.
9 13 17 XBI PF GIF
9 13 17 XBI PF GIF

  Matched “”
x
Take Advantage Of Our Free
7-Day Trial, $71st Month Offer!
  • Action-Oriented Trade Set-Ups in Stocks & ETFs
  • Macro Analysis of the Broader Markets
  • Detailed Technical Guidance for each Trading Idea
  • Live Interaction w/ Mike & Our Member Community
  • And Much, Much More!
Join Now! - Special Offer!
Veteran Wall Street analyst and financial author, Mike provides detailed and timely analysis and trade set-ups on a range of markets. Read more...

Have Mike's “Out Front” morning analysis delivered FREE to your email inbox twice weekly!